Overview

Properties

Applications

Our Abpromise guarantee covers the use of ab58347 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB
  • Application notesWB: Use at a concentration of 1-5 µg/ml.


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • RelevanceNFX1 is a transcriptional repressor capable of binding to the conserved X box motif of HLA-DRA and other MHC class II genes in vitro. It may play a role in the inflammatory response, regulating its duration by limiting the period in which class II MHC molecules are induced by IFN gamma. The RING type zinc finger domain interacts with an ubiquitin conjugating enzyme (E2) and facilitates ubiquitination.
    • Cellular localizationNuclear
    • Database links
    • Alternative names
      • MGC20369 antibody
      • NFX 1 antibody
      • NFX1 antibody
      • NFX2 antibody
      • Nuclear transcription factor X box binding 1 antibody
      • Nuclear transcription factor X box binding protein 1 antibody
      • Transcriptional repressor NF X1 antibody
      see all

    Anti-NFX1 antibody images



    • Predicted band size : 123 kDa
      NFX1 antibody (ab58347) at 1ug/lane + HeLa cell lysate at 25ug/lane.

    References for Anti-NFX1 antibody (ab58347)

    ab58347 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab58347.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"